A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 326



Robert J Kurman, Ie-Ming Shih. Am J Pathol 2016
Times Cited: 396




List of shared articles



Times cited

MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer.
Megan L Hutchcraft, Holly H Gallion, Jill M Kolesar. Diagnostics (Basel) 2021
0

Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells.
Kaoru Abiko, Takuma Hayashi, Ken Yamaguchi, Masaki Mandai, Ikuo Konishi. Cancer Invest 2021
0

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
Cécile Le Page, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher, Anne-Marie Mes-Masson. Curr Drug Targets 2020
0

Translational genomics of ovarian clear cell carcinoma.
Saira Khalique, Christopher J Lord, Susana Banerjee, Rachael Natrajan. Semin Cancer Biol 2020
3



Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes.
Deepak N Subramanian, Magnus Zethoven, Simone McInerny, James A Morgan, Simone M Rowley, Jue Er Amanda Lee, Na Li, Kylie L Gorringe, Paul A James, Ian G Campbell. Nat Commun 2020
4

Molecular Trajectory of BRCA1 and BRCA2 Mutations.
Yuichiro Hatano, Maho Tamada, Mikiko Matsuo, Akira Hara. Front Oncol 2020
15

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome.
Kristyna Tomasova, Andrea Cumova, Karolina Seborova, Josef Horak, Kamila Koucka, Ludmila Vodickova, Radka Vaclavikova, Pavel Vodicka. Cancers (Basel) 2020
5